Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...] …
Category: Providers
In his first public comments since a key federal court decision on the 340B patient definition, the leader of a [...] …
After hospitals in Arkansas raised concerns over details of an agreement by Novo Nordisk to temporarily loosen contract pharmacy restrictions, [...] …
Two high-ranking Republican Arizona state senators have introduced a bill that would bar drug manufacturer restrictions on 340B contract pharmacy [...] …
The AIDS Healthcare Foundation (AHF) recently urged a federal appeals court to reverse a lower court’s decision to dismiss its [...] …
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...] …
340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’
A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...] …
New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...] …
A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...] …
Medicare administrative contractors (MACs) covering more than half the states have initiated lump sum repayments to 340B hospitals, after getting [...] …